Prestige Consumer Healthcare ROE 2010-2025 | PBH
Current and historical return on equity (ROE) values for Prestige Consumer Healthcare (PBH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Prestige Consumer Healthcare ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $0.21B | $1.84B | 12.17% |
| 2024-12-31 | $0.21B | $1.79B | 12.43% |
| 2024-09-30 | $0.21B | $1.73B | 12.30% |
| 2024-06-30 | $0.21B | $1.68B | 12.67% |
| 2024-03-31 | $0.21B | $1.66B | 13.33% |
| 2023-12-31 | $-0.08B | $1.60B | -5.34% |
| 2023-09-30 | $-0.08B | $1.54B | -5.33% |
| 2023-06-30 | $-0.09B | $1.48B | -5.45% |
| 2023-03-31 | $-0.08B | $1.45B | -5.24% |
| 2022-12-31 | $0.21B | $1.69B | 12.98% |
| 2022-09-30 | $0.21B | $1.62B | 13.20% |
| 2022-06-30 | $0.20B | $1.59B | 13.15% |
| 2022-03-31 | $0.21B | $1.58B | 13.73% |
| 2021-12-31 | $0.19B | $1.52B | 13.14% |
| 2021-09-30 | $0.18B | $1.46B | 12.95% |
| 2021-06-30 | $0.18B | $1.42B | 13.40% |
| 2021-03-31 | $0.17B | $1.36B | 12.80% |
| 2020-12-31 | $0.17B | $1.32B | 13.36% |
| 2020-09-30 | $0.16B | $1.28B | 13.58% |
| 2020-06-30 | $0.15B | $1.23B | 13.03% |
| 2020-03-31 | $0.14B | $1.17B | 12.51% |
| 2019-12-31 | $-0.03B | $1.16B | -3.04% |
| 2019-09-30 | $-0.03B | $1.11B | -2.99% |
| 2019-06-30 | $-0.04B | $1.10B | -3.11% |
| 2019-03-31 | $-0.04B | $1.10B | -3.07% |
| 2018-12-31 | $0.06B | $1.23B | 5.29% |
| 2018-09-30 | $0.34B | $1.19B | 28.63% |
| 2018-06-30 | $0.34B | $1.16B | 30.53% |
| 2018-03-31 | $0.34B | $1.18B | 32.76% |
| 2017-12-31 | $0.39B | $1.22B | 41.21% |
| 2017-09-30 | $0.11B | $0.90B | 12.79% |
| 2017-06-30 | $0.11B | $0.86B | 13.39% |
| 2017-03-31 | $0.07B | $0.82B | 8.80% |
| 2016-12-31 | $0.07B | $0.80B | 9.42% |
| 2016-09-30 | $0.07B | $0.78B | 9.14% |
| 2016-06-30 | $0.07B | $0.74B | 9.42% |
| 2016-03-31 | $0.10B | $0.74B | 14.21% |
| 2015-12-31 | $0.11B | $0.72B | 16.31% |
| 2015-09-30 | $0.10B | $0.69B | 15.93% |
| 2015-06-30 | $0.09B | $0.66B | 13.95% |
| 2015-03-31 | $0.08B | $0.63B | 12.91% |
| 2014-12-31 | $0.07B | $0.61B | 11.90% |
| 2014-09-30 | $0.05B | $0.59B | 9.09% |
| 2014-06-30 | $0.07B | $0.59B | 12.35% |
| 2014-03-31 | $0.07B | $0.56B | 13.59% |
| 2013-12-31 | $0.08B | $0.54B | 14.74% |
| 2013-09-30 | $0.09B | $0.54B | 17.21% |
| 2013-06-30 | $0.07B | $0.50B | 15.15% |
| 2013-03-31 | $0.07B | $0.48B | 14.51% |
| 2012-12-31 | $0.05B | $0.46B | 10.72% |
| 2012-09-30 | $0.04B | $0.44B | 10.59% |
| 2012-06-30 | $0.04B | $0.42B | 9.42% |
| 2012-03-31 | $0.04B | $0.40B | 9.66% |
| 2011-12-31 | $0.04B | $0.40B | 11.48% |
| 2011-09-30 | $0.04B | $0.39B | 9.69% |
| 2011-06-30 | $0.03B | $0.38B | 9.41% |
| 2011-03-31 | $0.03B | $0.36B | 8.24% |
| 2010-12-31 | $0.03B | $0.36B | 7.56% |
| 2010-09-30 | $0.04B | $0.35B | 10.41% |
| 2010-06-30 | $0.03B | $0.34B | 10.41% |
| 2010-03-31 | $0.03B | $0.33B | 10.08% |
| 2009-12-31 | $-0.18B | $0.33B | -58.95% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.900B | $1.138B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.616B | 27.97 |
| Boston Scientific (BSX) | United States | $153.611B | 38.46 |
| Stryker (SYK) | United States | $149.817B | 31.33 |
| EssilorLuxottica (ESLOY) | France | $128.259B | 0.00 |
| Medtronic (MDT) | Ireland | $112.441B | 15.94 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.320B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.596B | 26.03 |
| ResMed (RMD) | United States | $37.597B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.163B | 16.22 |
| Agilent Technologies (A) | United States | $33.875B | 22.08 |
| Terumo (TRUMY) | Japan | $24.770B | 32.17 |
| Koninklijke Philips (PHG) | Netherlands | $22.956B | 16.11 |
| Insulet (PODD) | United States | $21.162B | 83.07 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.315B | 11.76 |
| Baxter (BAX) | United States | $15.236B | 11.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.113B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.723B | 23.40 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Perrigo (PRGO) | Ireland | $3.676B | 9.32 |
| Haemonetics (HAE) | United States | $3.609B | 16.44 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| ICU Medical (ICUI) | United States | $3.192B | 23.54 |
| QuidelOrtho (QDEL) | United States | $1.976B | 13.59 |
| LeMaitre Vascular (LMAT) | United States | $1.875B | 41.91 |
| AtriCure (ATRC) | United States | $1.561B | 0.00 |
| Acuren (TIC) | United States | $1.375B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.248B | 12.67 |
| Phibro Animal Health (PAHC) | United States | $1.212B | 15.49 |
| Green Thumb Industries (GTBIF) | United States | $1.163B | 26.16 |
| Neogen (NEOG) | United States | $1.081B | 13.83 |
| BioLife Solutions (BLFS) | United States | $1.036B | 0.00 |
| InMode (INMD) | Israel | $0.954B | 9.62 |
| Kestra Medical Technologies (KMTS) | United States | $0.757B | 0.00 |
| Owens & Minor (OMI) | United States | $0.669B | 5.55 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.662B | 0.00 |
| CeriBell (CBLL) | United States | $0.622B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.507B | 0.00 |
| Valneva SE (VALN) | France | $0.488B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
| Surmodics (SRDX) | United States | $0.424B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.344B | 12.67 |
| SNDL (SNDL) | Canada | $0.326B | 0.00 |
| Quanterix (QTRX) | United States | $0.315B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.284B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| ZimVie (ZIMV) | United States | $0.263B | 11.94 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| Brainsway (BWAY) | Israel | $0.253B | 66.85 |
| Aurora Cannabis (ACB) | Canada | $0.249B | 73.83 |
| Cresco Labs (CRLBF) | United States | $0.247B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.228B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Organigram Global (OGI) | Canada | $0.186B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.13 |
| Omeros (OMER) | United States | $0.180B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.129B | 15.90 |
| Apyx Medical (APYX) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.37 |
| Jin Medical (ZJYL) | China | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Zynex (ZYXI) | United States | $0.076B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.070B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 58.29 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Safety Shot (SHOT) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.10 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |